Lung cancer pill may cloud thinking: new study investigates

NCT ID NCT06781905

Recruiting now Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated May 02, 2026 · Updated 16 times

Summary

This study looks at memory, mood, and thinking problems that can happen with certain targeted lung cancer pills (ALK/ROS1 inhibitors). Researchers will work with 20 patients to better understand these side effects and how they affect daily life. The goal is to create a better care plan that includes both patients and doctors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Day care Hospital, Pierre Wertheimer Hospital, Civil Hospitals of Lyon
RECRUITING

Bron, 69500, France

Contact Email: •••••@•••••

Contact
Pneumology service, Louis Pradel Hospital, Civil Hospitals of Lyon
RECRUITING

Bron, 69500, France

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

METASTATIC LUNG CANCER METASTATIC LUNG CANCER WITH ALK/ROS1 FUSION